BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uenishi T, Nagano H, Marubashi S, Hayashi M, Hirokawa F, Kaibori M, Matsui K, Kubo S. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol. 2014;110:176-181. [PMID: 24760391 DOI: 10.1002/jso.23611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Sheng YY, Dong QZ, Qin LX. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. World J Gastroenterol 2016; 22(10): 3038-3051 [PMID: 26973400 DOI: 10.3748/wjg.v22.i10.3038] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
2 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
3 Abe T, Amano H, Shimamoto F, Hattori M, Kuroda S, Kobayashi T, Tashiro H, Ohdan H. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy. European Journal of Surgical Oncology (EJSO) 2015;41:1515-21. [DOI: 10.1016/j.ejso.2015.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
4 Fiorino S, Bacchi-Reggiani L, de Biase D, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Acquaviva G, di Tommaso L, Bondi A, Visani M, Sabbatani S, Pontoriero L, Fabbri C, Cuppini A, Pession A, Jovine E. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World J Gastroenterol 2015; 21(45): 12896-12953 [PMID: 26668515 DOI: 10.3748/wjg.v21.i45.12896] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
5 Nagaoka S, Yamada D, Eguchi H, Yokota Y, Iwagami Y, Asaoka T, Noda T, Kawamoto K, Gotoh K, Kobayashi S, Miyoshi E, Doki Y, Mori M. The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma. Cancer Sci 2021;112:347-58. [PMID: 33098728 DOI: 10.1111/cas.14709] [Reference Citation Analysis]
6 Gao ZJ, Wang FS. Current diagnosis and treatment of primary intrahepatic cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(31): 4939-4945 [DOI: 10.11569/wcjd.v23.i31.4939] [Reference Citation Analysis]
7 Kaibori M, Yoshii K, Kashiwabara K, Kokudo T, Hasegawa K, Izumi N, Murakami T, Kudo M, Shiina S, Sakamoto M, Nakashima O, Matsuyama Y, Eguchi S, Yamashita T, Takayama T, Kokudo N, Kubo S. Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey. Hepatol Res 2021;51:890-901. [PMID: 34041804 DOI: 10.1111/hepr.13676] [Reference Citation Analysis]
8 Iida H, Kaibori M, Tanaka S, Takemura S, Wada H, Hirokawa F, Nakai T, Hayashi M, Eguchi H, Kubo S. Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma. World J Surg 2017;41:1082-8. [PMID: 27896410 DOI: 10.1007/s00268-016-3843-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nishioka T, Kubo S, Tanaka S, Wakasa K, Takemura S, Kinoshita M, Hamano G, Kuwae Y, Shibata T, Suehiro S. Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up. Liver Cancer 2016;5:107-20. [PMID: 27386429 DOI: 10.1159/000367752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Ito T, Shinkawa H, Takemura S, Tanaka S, Nishioka T, Miyazaki T, Ishihara A, Kubo S. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma. Asian Pac J Cancer Prev 2020;21:2373-9. [PMID: 32856868 DOI: 10.31557/APJCP.2020.21.8.2373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]